FDA — authorised 22 September 2017
- Application: ANDA208682
- Marketing authorisation holder: MSN
- Indication: Labeling
- Status: approved
🇺🇸 Moxifloxacin Hydrochloride Tablets in United States
FDA authorised Moxifloxacin Hydrochloride Tablets on 22 September 2017
Marketing authorisation
Moxifloxacin Hydrochloride Tablets in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Moxifloxacin Hydrochloride Tablets approved in United States?
Yes. FDA authorised it on 22 September 2017.
Who is the marketing authorisation holder for Moxifloxacin Hydrochloride Tablets in United States?
MSN holds the US marketing authorisation.